Cover Image

Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity

Inhibitor-1 (I-1) modulates protein phosphatase 1 (PP1) activity and thereby counteracts the phosphorylation by kinases. I-1 is downregulated and deactivated in failing hearts, but whether its role is beneficial or detrimental remains controversial, and opposing therapeutic strategies have been prop...

Full description

Saved in:
Bibliographic Details
Main Authors: Neef, Stefan (Author) , Dewenter, Matthias (Author) , Saadatmand, Ali R. (Author) , Backs, Johannes (Author)
Format: Article (Journal)
Language:English
Published: 27 April 2017
In: Naunyn-Schmiedeberg's archives of pharmacology
Year: 2017, Volume: 390, Issue: 8, Pages: 857-862
ISSN:1432-1912
DOI:10.1007/s00210-017-1376-1
Online Access:Verlag, Volltext: http://dx.doi.org/10.1007/s00210-017-1376-1
Verlag, Volltext: https://link.springer.com/article/10.1007/s00210-017-1376-1
Get full text
Author Notes:Stefan Neef, Jordi Heijman, Kristian Otte, Matthias Dewenter, Ali R. Saadatmand, Stefanie Meyer-Roxlau, Christopher L. Antos, Johannes Backs, Dobromir Dobrev, Michael Wagner, Lars S. Maier, Ali El-Armouche

MARC

LEADER 00000caa a2200000 c 4500
001 1575503891
003 DE-627
005 20230427042911.0
007 cr uuu---uuuuu
008 180525s2017 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00210-017-1376-1  |2 doi 
035 |a (DE-627)1575503891 
035 |a (DE-576)505503891 
035 |a (DE-599)BSZ505503891 
035 |a (OCoLC)1341010097 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Neef, Stefan  |e VerfasserIn  |0 (DE-588)1160091919  |0 (DE-627)1023232901  |0 (DE-576)505503174  |4 aut 
245 1 0 |a Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity  |c Stefan Neef, Jordi Heijman, Kristian Otte, Matthias Dewenter, Ali R. Saadatmand, Stefanie Meyer-Roxlau, Christopher L. Antos, Johannes Backs, Dobromir Dobrev, Michael Wagner, Lars S. Maier, Ali El-Armouche 
264 1 |c 27 April 2017 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 25.05.2018 
520 |a Inhibitor-1 (I-1) modulates protein phosphatase 1 (PP1) activity and thereby counteracts the phosphorylation by kinases. I-1 is downregulated and deactivated in failing hearts, but whether its role is beneficial or detrimental remains controversial, and opposing therapeutic strategies have been proposed. Overactivity of Ca2+/calmodulin-dependent protein kinase II (CaMKII) with hyperphosphorylation of ryanodine receptors (RyR2) at the CaMKII-site is recognized to be central for heart failure and arrhythmias. Using an I-1-deficient mouse line as well as transfected cell lines, we investigated the effects of acute and chronic modulation of I-1 on CaMKII activity and RyR2 phosphorylation. We demonstrate that I-1 acutely modulates CaMKII by regulating PP1 activity. However, while ablation of I-1 should thus limit CaMKII-activation, we unexpectedly found exaggerated CaMKII-activation under β-adrenergic stress upon chronic loss of I-1 in knockout mice. We unraveled that this is due to chronic upregulation of the exchange protein activated by cAMP (EPAC) leading to augmented CaMKII activation, and using computational modeling validated that an increase in EPAC expression can indeed explain our experimental findings. Interestingly, at the level of RyR2, the increase in PP1 activity more than outweighed the increase in CaMKII activity, resulting in reduced RyR phosphorylation at Ser-2814. Exaggerated CaMKII activation due to counterregulatory mechanisms upon loss of I-1 is an important caveat with respect to suggested therapeutic I-1-inhibition, as CaMKII overactivity has been heavily implicated in several cardiac pathologies. 
700 1 |a Dewenter, Matthias  |e VerfasserIn  |0 (DE-588)1148565558  |0 (DE-627)1008763721  |0 (DE-576)496327763  |4 aut 
700 1 |a Saadatmand, Ali R.  |e VerfasserIn  |0 (DE-588)1160092400  |0 (DE-627)1023233703  |0 (DE-576)505503808  |4 aut 
700 1 |a Backs, Johannes  |d 1971-  |e VerfasserIn  |0 (DE-588)123819040  |0 (DE-627)706437462  |0 (DE-576)293892946  |4 aut 
773 0 8 |i Enthalten in  |t Naunyn-Schmiedeberg's archives of pharmacology  |d Berlin : Springer, 1873  |g 390(2017), 8, Seite 857-862  |h Online-Ressource  |w (DE-627)254638309  |w (DE-600)1462940-9  |w (DE-576)074531433  |x 1432-1912  |7 nnas  |a Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity 
773 1 8 |g volume:390  |g year:2017  |g number:8  |g pages:857-862  |g extent:6  |a Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity 
856 4 0 |u http://dx.doi.org/10.1007/s00210-017-1376-1  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s00210-017-1376-1  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180525 
993 |a Article 
994 |a 2017 
998 |g 123819040  |a Backs, Johannes  |m 123819040:Backs, Johannes  |d 910000  |d 910100  |e 910000PB123819040  |e 910100PB123819040  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 1160092400  |a Saadatmand, Ali R.  |m 1160092400:Saadatmand, Ali R.  |d 910000  |d 910100  |e 910000PS1160092400  |e 910100PS1160092400  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1148565558  |a Dewenter, Matthias  |m 1148565558:Dewenter, Matthias  |d 910000  |d 910100  |e 910000PD1148565558  |e 910100PD1148565558  |k 0/910000/  |k 1/910000/910100/  |p 4 
999 |a KXP-PPN1575503891  |e 3010156472 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Stefan Neef, Jordi Heijman, Kristian Otte, Matthias Dewenter, Ali R. Saadatmand, Stefanie Meyer-Roxlau, Christopher L. Antos, Johannes Backs, Dobromir Dobrev, Michael Wagner, Lars S. Maier, Ali El-Armouche"]},"relHost":[{"pubHistory":["1.1873 -"],"disp":"Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activityNaunyn-Schmiedeberg's archives of pharmacology","origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedKey":"1873","dateIssuedDisp":"1873-","publisher":"Springer"}],"part":{"text":"390(2017), 8, Seite 857-862","issue":"8","extent":"6","year":"2017","pages":"857-862","volume":"390"},"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["254638309"],"issn":["1432-1912"],"zdb":["1462940-9"]},"language":["eng"],"titleAlt":[{"title":"Archives of pharmacology"},{"title":"Archiv für experimentelle Pathologie und Pharmakologie"},{"title":"Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie"},{"title":"Naunyn-Schmiedebergs Archiv für Pharmakologie und experimentelle Pathologie"},{"title":"Naunyn-Schmiedebergs Archiv für Pharmakologie"}],"recId":"254638309","title":[{"title":"Naunyn-Schmiedeberg's archives of pharmacology","title_sort":"Naunyn-Schmiedeberg's archives of pharmacology"}],"note":["Gesehen am 19.10.05"],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"27 April 2017"}],"note":["Gesehen am 25.05.2018"],"title":[{"title":"Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity","title_sort":"Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity"}],"person":[{"family":"Neef","display":"Neef, Stefan","roleDisplay":"VerfasserIn","role":"aut","given":"Stefan"},{"display":"Dewenter, Matthias","family":"Dewenter","roleDisplay":"VerfasserIn","role":"aut","given":"Matthias"},{"display":"Saadatmand, Ali R.","family":"Saadatmand","roleDisplay":"VerfasserIn","role":"aut","given":"Ali R."},{"role":"aut","given":"Johannes","roleDisplay":"VerfasserIn","display":"Backs, Johannes","family":"Backs"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"id":{"doi":["10.1007/s00210-017-1376-1"],"eki":["1575503891"]},"physDesc":[{"extent":"6 S."}],"recId":"1575503891"} 
SRT |a NEEFSTEFANCHRONICLOS2720 

Similar Items